Chemed (CHE)

• Market cap: $8.31B
• 1 day: 0.33%
• 5 days: 6.33%
• 1 month: 5.67%
• 3 months: -9.45%
• 6 months: 1.01%
• Year to date: 5.07%
• 1 year: -5.45%
• 5 years: 17.07%
• 10 years: 439.41%
• Sector: Healthcare
• Industry: Home Health Care Services

About: Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.

Employees: 15,087

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

150% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 5 (+3) [Q3]

31% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 52

2% more funds holding

Funds holding: 511 [Q2] → 521 (+10) [Q3]

5% more call options, than puts

Call options by funds: $2.34M | Put options by funds: $2.22M

4% more capital invested

Capital invested by funds: $8.17B [Q2] → $8.5B (+$327M) [Q3]

3% more repeat investments, than reductions

Existing positions increased: 184 | Existing positions reduced: 179

5.56% less ownership

Funds ownership: 99.52% [Q2] → 93.96% (-5.56%) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $633 14% upside
• Avg. target: $633 14% upside
• High target: $633 14% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

RBC Capital Ben Hendrix 29% 1-year accuracy 20 / 70 met price target

14% upside $633

Outperform Maintained

5 Nov 2024